Patent · US Active

Method of treating cancer

US11298376B2 · kind B2 · utility

1Cited by

6References

30Claims

0Family size

Assignee

TARGIMMUNE THERAPEUTICS AG · CH

Inventors

Alex Levitzki · Jerusalem, IL
Salim Joubran · Lod, IL
Alexei Shir · Jerusalem, IL
Maya Zigler · Basel, CH
Alaa Talhami · Arraba, IL
Yael Langut · Haifa, IL

Key dates

Filing date	Mar 7, 2019
Grant date	Apr 12, 2022
Priority date	—
Expiry date	Feb 25, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating cancer can include administering a polyplex of a double stranded RNA and a polymeric conjugate. The polymeric conjugate can consist of a linear polyethyleneimine covalently linked to one or more polyethylene glycol (PEG) moieties. Each PEG moiety can be conjugated via a linker to a targeting moiety capable of binding to a cancer antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.